Research, Development & Innovation
ITClinical is committed to continuous technological evolution. Through strategic co-funding by the European Union under the Plano de Recuperação e Resiliência (PRR), we are scaling our artificial intelligence capabilities and global digital footprint.
HEALTHY AI
Adoption of artificial intelligence to multiply productivity, automate software development life cycles, streamline document quality control, and expand our footprint in highly regulated global markets.
- Eligible Investment: €218.922,68
- EU Financial Support (FEDER): €164.192,01
- Execution Period: 01-11-2025 – 31-10-2027
Internacionalização via E-Commerce
Implementation of a detailed international e-commerce and digital marketing strategy to scale our specialized clinical trial and pharmacovigilance solutions globally (Bibliovigilance, OneVigilance, eCRF, IWRS).
- Eligible Investment: €24.999,10
- EU Financial Support (FEDER): €12.499,55
- Execution Period: 11-11-2025 – 30-06-2026